Biblio

Filters: Author is Sorà, Federica [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.

I

Iurlo, A., Nobili, A., Latagliata, R., Bucelli, C., Castagnetti, F., Breccia, M., Abruzzese, E., Cattaneo, D., Fava, C., Ferrero, D., et al. (2016). Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.Oncotarget.

O

Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.